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The proliferative response of human T  cells cultured  with autologous non-T cells 
is known as the autologous mixed lymphocyte reaction  (AMLR) 1 (1-3). The stimuli 
for  proliferation  remain  unclear,  but  probably  include  xenoantigens  (4)  Ia-like 
materials  presented on dendritic,  macrophage, B, or null cells (5-7). In the course of 
the  AMLR,  T  cell  subsets  are  expanded,  which  both  helps  autologous  B  cells  to 
synthesize  immunoglobulin  (Ig)  and  demonstrates  suppressor  functions  (8-10).  Si- 
multaneously,  mitogenic factors,  such as interleukin  2, are produced in the cultures 
(9,  11,  12). 
There is disagreement about the generation of cytotoxic cells in the AMLR. Vande 
Stouwe  et  al.  (13)  observed  that  AMLR  supernatants  induced  cells  that  killed 
allogeneic targets,  but  found no autologous cytotoxic T  cells.  Similarly,  it  has been 
reported  that  cytotoxic T  cells  do not  develop in the  murine  syngeneic MLR  (14). 
Miller and Kaplan  (15) also were unable to demonstrate cytotoxic effector cells in an 
AMLR where the targets were autologous unstimulated mononuclear cells or purified 
B  cells,  but  good  killing  of B  lymphocytes when  the  targets  were  LPS-stimulated 
mononuclear cells. Subsequently, Tomonari (16) reported that cytotoxic T  cells could 
be generated  in the AMLR  that  lysed autologous targets,  as well as various human 
lymphoid cell  lines.  The  AMLR  killers  had  some characteristics  similar  to natural 
killer  (NK) cells. We too observed a lymphocyte-mediated cytotoxicity to a variety of 
targets  in  response  to  autologous  stimulation,  but  the  responsive  cell  lacked  an  Fc 
receptor for IgG and thus differed from conventional NK cells (17). 
The present studies were performed to determine the conditions for the production 
of cytotoxic T  cells  in the autologous MLR, to define the surface phenotype of the 
responsible cells using monoclonal antibodies  (MAb),  and to distinguish  them from 
other cytotoxic effeetor cells, such as NK (18-20) and cytolytic T  lymphocytes (CTL) 
(21, 22). 
Materials  and Methods 
Media.  RPMI-10% fetal bovine serum (FBS)  consisted of RPMI supplemented  with  10% 
heat-inactivated FBS (Grand Island Biological Co., Grand Island, NY), 200 U  penieillin/ml, 
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10  #g  gentamycin/ml,  and  300  btg  L-glutamine/ml.  RPMI-20%  autologous  plasma  (AP) 
consisted  of RPMI  1640  containing  20%  heat-inactivated  AP,  200  U  penicillin/ml,  10  /~g 
gentamycin/ml, 300/~g L-glutamine/ml, 25 mM Hepes/ml (Grand Island Biological Co.), and 
0.05 mM 2-mercaptoethanol/ml  (Mallinckrodt Inc., Science Products Div., St. Louis, MO). 
Peripheral Blood Mononuclear Cell (PBM) Purification.  PBM from healthy volunteers (22-54 yr 
old)  of both  sexes were isolated by Ficoll-Hypaque (Pharmacia  Fine Chemicals,  Piscataway, 
N J) density gradient centrifugation  (23).  Cells aspirated from the interface were washed three 
times with  RPMI-10%  FBS.  PBM  (2  ×  107/ml)  were  mixed with  an  equal  volume of  10% 
neuraminidase-treated  (24)  sheep  erythrocytes  (SRBC)  in  SRBC-absorbed,  heat-inactivated 
FBS. After centrifugation at 70 g  for 5 min, the cell mixture was incubated at 37°C for 15 rain 
and at 4°C overnight. Pellets were gently aspirated and layered over a second Ficoll-Hypaque 
gradient.  The  erythrocyte-rosetting  T  (E  +)  cells were  recovered  in  the  pellet  and  the  non- 
erythrocyte-rosetting (E-) cells were collected from the interface. SRBC were lysed by hypotonic 
shock and  both  E + and  E- cell fractions  were washed  with  RPMI-10%  FBS three  times.  In 
some  experiments  in  which  fresh  NK  activity  was  assayed,  monocytes  were  depleted  of 
peripheral blood lymphocytes (PBL) by incubating PBM in FBS-coated plastic plates at 37°C 
for 1 h  (25). 
AMLR.  AMLR cultures were performed in multi-well tissue culture plates (Linbro 76-033- 
05;  Flow Laboratories,  Inc., Rockville, MD)  with  2.1  ×  106/well E + cells and  2.1  ×  106/well 
mitomycin C  (MMC)  (Sigma Chemical Co., St.  Louis, MO)  -treated  E- cells in 2.9 ml/well 
RPMI-20%  AP.  Non-T cells (E-)  were treated  with  25 /Lg/ml of MMC  for 60  min  at  37°C 
followed by  three  washes  in  RPMI-10%  FBS,  and  resuspended  in  RPMI-20%  AP.  Control 
cultures of E + cells alone and MMC-treated E- cells alone at 2.1  ×  106 cells/2.9 ml in RPMI- 
20% AP were included in all experiments. Cultures were incubated at 37°C in a humidified 5% 
CO2 atmosphere. 
Cell  Viability and Proliferation of AMLR  Cultures.  Cells recovered from  AMLR  and  control 
cultures  were washed  three  times with  RPMI-10%  FBS and  the number  of viable cells was 
assessed by trypan  blue dye exclusion. Proliferative responses were determined by incubating 
2  X  105/0.2  ml  of cells recovered  from  AMLR  and  control  cultures  and  1 p,  Ci/well  [3H]- 
thymidine (Schwarz/Mann Div., Becton, Dickinson & Co., Orangeburg, NY) for 18 h at 37°C 
in a  humidified 5% CO2 atmosphere.  The plates were set up in triplicate in Linbro microtiter 
plates  (76-001-05;  Flow  Laboratories,  Inc.)  and  harvested  on  a  multiple  automatic  sample 
harvester (Otto Hiller; Madison, WI). The amount of incorporated isotope was measured in a 
liquid  scintillation  counter  (Beckman  Instruments,  Inc.,  Palo  Alto,  CA),  and  results  were 
expressed as the mean counts per minute of triplicate samples. 
MAb.  The characteristics of the individual MAb used in this study are presented in Table 
I. The OK reagents were from Ortho  Diagnostic Systems,  Westwood, MA; 9.3  and  9.6  from 
New  England  Nuclear,  Boston,  MA;  the  Leu-7  (HNK-1)  from  Becton,  Dickinson  &  Co., 
Mountain  View, CA.  T101  and  4F2  were generously provided  by I.  Royston  (University of 
California, San Diego) and A. Fauci (National Institutes of Health), respectively. As a control 
MAb, mouse IgG2a myeloma protein RPC-5  (Bionetics Laboratory Products, Litton Bionetics, 
Kensington,  MD) was used. 
Complement (C')-mediated Cell Lysis.  5 ×  10  s cells were incubated in 0.5 ml of cuhure medium 
containing the MAb at the final concentrations shown in Table I. Cells to be treated with C' 
alone  were  incubated  in  culture  medium  without  MAb.  After  a  1-h  incubation  at  22°C, 
carefully selected nontoxic rabbit  C' was added  at a  final dilution of 1:2, and  the ceils were 
incubated for  1 h  at 37°C. The cells were then pelleted and the C' was removed and replaced 
with  1 ml fresh C' diluted  1:2. The cells were then incubated for another hour at 22°C, layered 
on modified Ficoll-Hypaque gradients and centrifuged to deplete the dead cells (20,  42). The 
cells at  the interface of the gradients,  consisting of 98%  viable cells, were washed  thrice with 
RPMI-10% FBS before cytotoxicity assay. The percentage of residual antigen-positive cells after 
C' plus MAb treatment was usually <5%. 
Preparation of Aggregated IgG.  A  2% solution of rabbit  IgG (Cohn fraction II; Miles Labora- 
tories Inc., Elkhart,  IN) was heat aggregated at 63°C for 30 rain. Sodium sulfate (2.18 M) was 
added  and the mixture was incubated at 4°C for 30 min, and then centrifuged at 3,000 g  for 
30  rain.  The  sediment  was  resuspended  in  phosphate-buffered  saline  (PBS)  and  dialyzed MAKOTO GOTO AND NATHAN J.  ZVAIFLER 
TABLE  I 
Characteristics of MAb 
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Final con- 
MAb  Specificity  Ig subclass  Antigen  centration  mol wt  in C'-me-  Reference 
diated lysis 
×  10 -s 
9.3  Suppressor/killer T  IgGz~  44  1  : 100  26-28 
9.6  E +  IgG2b  50  1  : 100  27, 28 
T101  Pan T  IgGza  65  I : 1,000  29 
OKT4  Helper/inducer T  IgG2b  62  1:50  30-34 
OKT6  Thymocyte  IgG1  49  --*  30, 31, 34 
OKT8  Suppressor/killer T  IgG2,  76  1:50  30, 31, 34, 35, 38 
OKT9  Early hematopoietic  IgG1  94  --  30, 31, 34, 38 
stem cell, 
activated T 
OKT10  Early hematopoietic  IgG1  45  --  30, 31, 34, 38 
stem cell, 
monocyte, null 
cell activated T, B 
OKM 1  Monocyte,  IgG~b  173  1:50  36, 38 
granulocyte, null 
cell 
OKIax  Ia  + B, monocyte, T  IgG2  34  1:50  37, 38 
4F2  Monocyte,  IgG~a  120  l : 100  39, 40 
activated T 
Leu- 7  NK  IgM  NR:~  1  :  20  41 
*  Non-complement-fixing. 
:~ Not reported. 
extensively against PBS at 4°C. The solution was ultracentrifuged at 104,000 g for 90 min. The 
pellet was resuspended  in PBS and  centrifuged at  5,000 g  for 30 rain.  The final supernatant 
was used as an aggregated IgG at concentrations ranging from 3 to 300/zg/ml. 
Cell Surface Immunofluorescence.  1 ×  106 cells were incubated on ice for 45 min with appropriate 
dilutions of the MAb  (OKT4,  OKT6,  OKT8,  OKT9,  OKT10,  OKIal,  and  OKM1  diluted 
1:100; 9.6 and 4F2 diluted  1:1,000;  and Leu-7 diluted  1:20)  in buffer consisting of RPMI, 5% 
gamma globulin-free horse serum  (Grand Island Biological Co.), and 0.2% sodium azide. The 
cells were  washed  twice with  the  buffer  and  incubated  on  ice for  30  min  with  fluorescein- 
conjugated goat anti-mouse IgG or IgM (only for Leu-7) diluted 1:20 in buffer. Fc receptors for 
IgG were also detected by uptake  of heat-aggregated  rabbit  IgG by incubating  lymphocytes 
with 100 #g/ml of heat-aggregated IgG for 30 min at 4°C. After two washings, the cell surface- 
bound aggregate was visualized by incubating the cells with a fluorescein-conjugated goat anti- 
rabbit Fc antiserum for 30 min at 4°C (43). The fluorescein-conjugated reagents were purchased 
from N. L. Cappel  Laboratories Inc., Cochranville, PA. After three washings with buffer, the 
cells were examined for cell surface immunofluorescence using a  Zeiss fluorescent  microscope 
with epi-illumination (Carl Zeiss, Inc., Thornwood, NY). 
Target Cell Lines.  The K562 erythroleukemic cell line (44)  and two Burkitt lymphoma lines, 
Raji and  Daudi, were grown in suspension  culture  in RPMI-10% FBS. The K562 cell line is 
sensitive to  NK lysis  (18)  and  both  Raji  and  Daudi  cell lines are resistant  to NK lysis  (45). 
Daudi is also resistant to CTL-mediated lysis (45, 46). Both K562 and Daudi lack HLA antigens 
(45). 
Cytotoxicity  Assay.  Target cells were radiolabelled by incubating  5 ×  106 cells with 0.05  ml 
N  sl  rO  -  o  a2  C  4 (sp act  1.0 mCl/ml; New England Nuclear) for 2 h at 37  C with occasional shaking 
followed by at least three washings with the medium (18). Target cells (1 ×  l04 containing ~8- 1312  AUTOLOGOUS  MIXED  LYMPHOCYTE  REACTION-GENERATED  KILLER  CELLS 
20 ×  10  a cpm) in 0.1 ml medium were mixed with 200,000-25,000 viable effector cells in 0. i ml 
media to give effector to target (E/T) rauos of 20:1  to 2.5:1, in wells of sterilized mmromer V- 
plates (Dynatech Laboratories, Alexandria, VA). The plates were centrifuged for 5 rain at 60 
g to facilitate the contact between the effector and target cells, and then incubated for 4 h  at 
37°C in humidified air plus 5% CO2. After the incubation, the plates were centrifuged for 10 
rain at  150 g. An aliquot of the supernatant (100 gl) was removed from each well and counted 
in  an  automatic  gamma scintillation counter.  Spontaneous release of 51Cr was  assessed by 
incubating the target cells in media without the effector cells in the same procedure. In a typical 
experiment, spontaneous release was <5%. Maximum release was obtained by suspending the 
labeled target cells in  0.1  N  HC1.  All  tests were performed in  triplicate.  Differences among 
percent release in triplicates were within 5%. The percentage ofcytotoxic activity was calculated 
as follows: [(experimental 5aCt release -  spontaneous 51Cr release)/(maximum 51Cr release - 
spontaneous 51Cr release)] ×  100. In the cytotoxicity assay described above, the effector cells in 
the NK test were fresh PBL, and the AMLR cytotoxic cells were E + cells obtained by overnight 
rosetting with SRBC at various times throughout the culture period for 3-12 d. 
Blocking  Experiments.  The  ability  of either  MAb  or  heat-aggregated  IgG  to  block  the 
cytotoxic activity of fresh NK- and AMLR-generated cells was tested in the following manner. 
MAb  (10 gl)  at  1.5  gg/ml  (or 4F2  at  1:100  dilution)  or aggregated IgG  (3-300/.tg/ml)  was 
added to  1 ×  105  (for AMLR killer activity) or 2 ×  10  ~ (for fresh NK activity) effector cells in 
the assay wells. This mixture was maintained at  room temperature for  1 h, and chromium- 
labeled  target  cells  (1  ×  104) in  a  final  volume  of 200  gl  were  added  to  each  well.  The 
cytotoxicity assay  and  the  determination of cytotoxic  activity  were  carried  out  exactly  as 
described above. 
Results 
Analysis of Cell Proliferation in the AMLR.  Cell proliferation, as measured by [3H]- 
thymidine  incorporation,  and  the  viability  of  E +  cells  cultured  with  autologous 
mitomycin-treated E- cells was compared with unstimulated E + cells. Cell prolifera- 
tion was demonstrable by day 3, and the peak [3H]thymidine incorporation occurred 
on day 7. The maximum number of viable cells recovered from the AMLR cultures 
varied from donor to donor between the 5th and 9th d. Almost all the MMC-treated 
E- cells were dead after 3 d  in culture (Table II). 
The surface markers of the cells generated after 7 d in AMLR culture are compared 
with the characteristics of the input cells in Table III. Most of the cells stained with 
the MAb 9.6.  There were modest changes in the OKT4  + and OKT8  + populations. 
Cells bearing Ia antigen and the 4F2 marker were significantly increased. In contrast, 
TABLr  II 
Percent Survival  of Cultured Cells in AMLR 
AMLR culture  Control culture 
Days in 
culture  E  + + E~MC*  E + alone  E~MC alone§ 
1  65,5 -- 6.0  47.5 +  18.6  35 
3  77.3 -+ 4.9  49.7 +  18.0  15 
5  83.4 +  23.1  47.7 +  17,0  5 
7  83.2 +  31.3  48.0 +  19.1  0 
9  110.9 +-. 63.2  52,5 +-- 14.3  0 
12  94.1 +  51.2  40.5 +  19.5  ND~: 
20  38.1§  7.1§  ND 
* E + cells were cultured with mitomycin C-treated autologous  E- cells. 
:1: Not Done. 
§ Mean of two experiments. Others were mean +  SD of 12 experiments. Staining 
with MAb 
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TABLE III 
Cell Populations Generated in AMLR Culture 
Before culture  After 7 d culture 
E  +*  E-  E  +  E  + + E~t~c:~ 
9.6  84.0 ± 8.4  14.4 ± 6.3  92.7 ± 6.0  95.8 --- 1.6 
OKT4  52.3 ± 7.6  8.3 ± 3.8  67.2 -  7.3  66.8 -- 7.3 
OKTe§  0  0  0  0 
OKTs  31.0 ± 8.8  6.0 ± 3.2  25.4 ± 5.1  25.6 ± 7.5 
OKTg§  0  0  0  1.7 ±  1.7 
OKTa0§  0  0  0  8.7 ± 3.7 
OKIaa  11.5 + 7.4  73.8 ± 2.9  3.5 ± 2.9  39.2 ±  17.4 
4F2  4.7±4.0  45.5± 13.5  8.4±6.6  68.3± ll.1 
OKMx  19.2 ± 6.1  46.5 ± 9.3  4.0 ± 2.9  4.4 ± 3.6 
Leu-7  22.7 ± 6.6  7.0 ± 6.9  7.9 ± 3.7  4.4 ± 2.3 
Agg IgG[[  20.3 ± 6.7  60.0 ±  10.3  4.5 ±  1.2  4.3 ± 3.9 
* E  + cells. 
:[: E- cells treated with mitomycin C were used as stimulators in AMLR culture 
and no E- cells survived after 7 d culture. 
§ Mean ± SD of three experiments. Others were of 12 experiments. 
]] Detection of IgG Fc receptor positive cells by aggregated IgG. 
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there were significant reductions in the OKM1 + cells, Leu-7  + cells, and cells with Fc 
receptors. Small numbers of OKT9  + and OKT 10  + cells that were not apparent before 
culture could be demonstrated after  7 d.  In all the AMLR cultures, the percent of 
4F2  + cells was always much higher than that of OKIal + cells. 
Generation  of AMLR  Cytotoxic  Cells.  As  previously reported,  AMLR  killer  cells 
develop when cultured in fresh AP or serum (16). Aged AP or serum (1  mo or 3 mo 
stored  at  -20°C),  fresh heterologous plasma or serum from donors with similar or 
different blood types, and fetal calf serum all were much less supportive of cytotoxic 
cell production (50% or greater reduction in ~lCr release from target cells). 
The kinetics of AMLR-generated killer cell activity against three different cell lines 
at  a  20:1  E/T  ratio are shown in Fig.  1.  Cells able to lyse K562,  Daudi, and Raji 
targets generally appeared on day 5 and were maximally cytolytic on day 7 or 9  of 
culture.  K562 cells appeared  to  be the most  susceptible targets  for AMLR  killing; 
Raji cells were least sensitive (Fig. 2). 
The effect on cytotoxicity of adding increasing concentrations of aggregated IgG to 
E + cells at various times during the AMLR culture is shown in Fig. 3. On day 0  (the 
E ÷  obtained through overnight E  rosetting), the  lysis of K562 targets was reduced 
significantly by 30 and 300 #g of aggregated IgG. A similar effect was seen on day 3, 
but by day 7 the AMLR killer activity was influenced only slightly by the addition 
of aggregated IgG. These findings suggest that most of the cytotoxicity is exerted by 
Fc- cells, with a  small participation from the 4-5% of Fc  + ceils that survive cultures 
for 1 wk (Table III). 
Characterization of the AMLR Cytotoxic Cell with MAb.  The cytotoxic cells generated 
in  a  7-d  AMLR  culture were  treated  with  a  variety of MAb  plus  C',  and  their 
susceptibility was compared with fresh NK activity against a  K562 cell line. Conven- 
tional NK activity was significantly  reduced only by treatment with MAb 9.6, OKM1, 
and  Leu-7  (Fig.  4).  C'  lysis with  MAb to  the  cell  surface  antigens of activated T 
lymphocytes (4F2 and OKIal)  caused only slight reduction. In contrast to the NK 1314  AUTOLOGOUS  MIXED  LYMPHOCYTE  REACTION-GENERATED  KILLER  CELLS 
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Fie.  l.  A  kinetic  analysis  of  AMLR  killer  cell  activity  against  three  cell  lines.  E +  cells  were 
removed from AMLR cultures at the times indicated  and tested for their cytotoxicity at an E/T 
ratio of 20:1  against targets K562  (0), Daudi  (E), and Raji  (&). The percent cytotoxicity by the 
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FIG.  2.  A comparison of the cytotoxicity of ceils  removed from AMLR culture on day 7 against 
targets K562 (O), Daudi (I), and Raji (&). Various E/T ratios were examined in a 4-h chromium- 
release assay. E ~" cells  that had been stimulated by non-T cells  (solid  lines)  were compared with 
non-stimulated E + cells  (broken lines). 
activity, the killing generated in the 7-d AMLR cultures was only eliminated by MAb 
9.6 or 4F2 plus C' treatment. NK-specific MAb OKM1 and Leu-7 did not reduce the 
AMLR  killing  significantly  (Fig.  5).  There  was  slight,  but  probably  significant 
reduction  of AMLR cytotoxic activity against the K562 cell line by treatment with 
anti-Ia plus C'. A strong correlation could be demonstrated between the percentage 
of cells in a  7-d AMLR culture that stained with the MAb 4F2 and the percent lysis 
of K562 targets (y -- 0.87, P  <  0.002)  (Fig. 6). Of particular interest was the finding 
that MAb specific for cytotoxic T  cells (OKT8 and 9.3)  had no inhibitory effect on 
either NK or AMLR-generated cytotoxicity. In fact, in most cases, these antibodies 
increased  both  types  of  killing.  C'-mediated  lysis  with  OKT4  antibody  always 
enhanced  AMLR  killing  presumably because  the  removal of the  large  number of 
OKT4  + cells  increased  the  proportion  of the cytotoxic effectors in  the residual  cell MAKOTO GOTO AND NATHAN J.  ZVAIFLER 
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FIG. 3.  The effect of the addition of varying concentrations of aggregated IgG on cytotoxicity of 
cells taken at different times from AMLR culture. A 4-h chromium-release assay with K562 targets 
at an E/T ratio of 20:1 was performed with E + cells separated after overnight incubation (day 0) 
and from AMLR cultures on days 3 and 7. The percent lysis (O) represents  the difference between 
chromium released  by stimulated cells minus that released by the unstimulated cells. 
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FIo.  4.  NK cell activity against  K562  targets after treatment with MAb plus C'. C' alone (C)), 
OKT4 + C' (O), OKT8 + C' (A), 9.3 + C' (®), 4F2 + C' ~1), OKIax + C' (11), T101  + C' (V), Leu- 
7 +  C' (*), 9.6 +  C' (V), and OKM1 +  C' (A). 
population.  Resuhs  similar  to  those  shown  in  Fig.  5  were  seen  in  four  separate 
experiments  and  also when Raji cells were used as targets. 
The  susceptibility  of fresh  NK-  and  AMLR-generated  cytotoxic cells to  blockade 
by  MAb  was  assayed  by  adding  1.5/.tg/ml  (final  concentration)  of each  individual 
antibody  in the absence of C'. With  the exception of a  slight amount  of blocking by 
MAb  9.6,  there  was  no  significant  effect  from  the  addition  of any  MAb  to  either 
cytotoxic effector cell assay. 
Relative Importance of Ial +- and 4F2+-bearing Cells as AMLR Killers.  The role of cells 
with an  Ial +  or 4F2 + phenotype  was studied further by establishing AMLR  cultures 
for  7  d,  treating  the  remaining  cell population  with  MAb  plus  C' or C' alone,  then 
pulsing with [3H]thymidine and harvesting  18 h  later. The cytotoxicity of the residual 
cells was  determined  using  K562  as  targets.  The  relationship  between  AMLR  killer 1316  AUTOLOGOUS  MIXED  LYMPHOCYTE  REACTION-GENERATED  KILLER  CELLS 
50 
40 
3O 
o~ 
.J 
20 
10 
tacget  K~2 
_  ~"~"~ 
i 
2.5:1  5:1  10:1 
E/T Ratio 
2;:t 
F[c.  5.  The cytotoxic activity of E + cells  removed from AMLR culture at  7 d  on K562  targets 
after treatment with MAb and C'. See Fig. 4 for the designations of C' alone or with the individual 
MAb. 
.J 
60 
40 
20 
y=  -50.2+1.3X 
(r = 0.87,  P< 0.002) 
/ 
I  I  I 
%  of 4F+Cells 
FIG.  6.  Correlation between the percentage of cells in a  7-d AMLR culture that stained with the 
MAb 4F2 and the percent lysis (uncorrected) of K562 targets (E/T,  10:1). 
activity  and  cell  proliferation  is  demonstrated  in  a  typical  experiment  (shown  in 
Table IV). Treatment  with OKIal  plus C' reduced  [3H]thymidine incorporation by 
~35%  and  cytotoxicity  by  a  similar  amount.  In  contrast,  4F2  plus  C'  treatment 
zompletely  eliminated  both  thymidine  incorporation  and  AMLR-induced  killing. 
These  results  suggest  that  the  majority  of the  cytotoxicity and  most  of the  DNA 
proliferation seen after  1 wk in culture is from 4F2 + cells. The role of the cells bearing 
the surface Ia antigen was studied  further,  since both 4F2 and OKIal  are known to 
be expressed on proliferating or activated T  cells. When cells taken after 7 d in AMLR MAKOTO GOTO AND NATHAN J.  ZVAIFLER  1317 
TABLE IV 
Relationship Between AMLR Killer Activity and Cell Proliferation 
Treatment 
C' alone  C' + OKIal  C' + 4F2 
aH incorporation*  38,390 + 22  24,086  :t: 834  1,128 ± 150 
AMLR killer activity:~  30.3  19.8  1.8 
* [3H]thymidine incorporation was expressed as CPM/2 × 102 cells. 
:~ AMLR killer activity (percent lysis) against K562 cell line was assessed at 
E/T ratio, 10:1. 
culture were treated with the respective MAb plus C', and then stained, it could be 
shown that 30% of the cells  surviving after OKIal plus C' treatment were 4F2  +, but 
that  no OKIal  + cells  remained  after  4F2  plus  C' treatment.  We would conclude, 
therefore, that AMLR killers are heterogeneous for the Ial phenotype; a  portion are 
positive but the majority are not. 
Discussion 
Despite  reports  to  the  contrary, cytotoxic effector cells  can  be  generated  in  the 
AMLR. Their appearance parallels the DNA synthetic response of the stimulated T 
cell population, but persists for several days longer, as shown by Tomonari (16) and 
in this paper. AMLR killers lyse a variety of targets, including human lymphoid cells 
of both the B and T  cell class, autologous B cell lines transformed by Epstein-Barr 
virus,  autologous and  allogeneic mitogen blasts,  and some xenogenic cell  lines  (16, 
17). 
The reason why some investigators failed to detect AMLR-generated cytotoxic cells 
is not clear. Tomonari (16) ascribed his success to the use of AP in the AMLR culture 
medium. Our findings are confirmatory; namely that fresh human plasma or serum 
or fetal calf serum are equally supportive of the proliferative response  (detected by 
[SH]thymidine uptake)  in  the  AMLR cultures,  but  that  efficient  cytotoxicity was 
dependent on the use of fresh human plasma  (or serum). An autologous source was 
better than heterologous plasma and the blood group status of the donor seemed to 
have no influence. The contribution of AP to the generation of AMLR killer activity 
requires further clarification, but in a  preliminary report, Hausman et al.  (47) have 
observed that serum from major histocompatibility complex-identical or haplo-iden- 
tical individuals is as effective as AP. 
Because of a  number of similarities, Tomonari (16) suggested that the auto-MLR 
cytotoxic effector was in the NK lineage. There are important differences, however, 
including the fact that his cytotoxic cells lysed autologous B cell lines and Daudi cells, 
which are usually insensitive  in short-term cytotoxicity assays to NK cells,  and  the 
observation that the AMLR killers are not Fc receptor-bearing cells  (17).  Because of 
these discrepancies, it was considered of interest to define further the AMLR cytotoxic 
effector cell with the use of MAb. 
Of the 12 MAb chosen, 9 react with distinct T cell differentiation antigens (9.6, 9.3, 
T101,  OKT4, OKT6, OKT8, OKT9, OKT10, and 4F2),  1 recognizes a  human Ia 
antigen  (OKIal),  1  the  NK  and  monocyte lineage  (OKM1),  and  2  (Leu-7  and 
OKM1)  human NK cells.  Most fresh NK cells  express antigens recognized by MAb 
9.6, OKM1, and Leu-7; C'-mediated lysis with these antibodies eliminated most of 1318  AUTOLOGOUS MIXED LYMPHOCYTE REACTION-GENERATED KILLER CELLS 
the cytotoxicity of PBL tested before establishment of the AMLR cultures  (Fig.  3). 
This  is  similar  to  the  findings  of Zarling  et  al.  (48,  49)  and  Fast  et  al.  (28)  who 
reported  that  C'-mediated  lysis  with  OKM1,  9.6,  or  OKTllA  (a  9.6  equivalent) 
efficiently abrogated  fresh  NK activity.  In contrast,  the  AMLR cytotoxic effectors 
were only eliminated by treatment with MAb 4F2 or 9.6 and C' and reduced by Ial + 
antibody treatment. Similar results were obtained with both K562 and the Raji cells 
as targets.  The cytotoxic cell is most likely from the T  lymphocyte lineage, because 
>95%  of the cells present at the end of 1 wk in the AMLR culture stain with MAb 
9.6, which  recognizes a  50,000  dalton  molecule on the surface of thymocytes and T 
cells and  because MAb  9.6  plus  C' treatment  abrogated most of the AMLR  killer 
activity. 
Fresh  NK cells  show  a  variable expression  of density  and  avidity of Fc  gamma 
receptors  (50).  Most  of the  fresh  NK activity can  be blocked by prior exposure to 
aggregated  IgG (18,  20).  In  contrast,  only a  slight  to  moderate  suppression  of the 
activity in AMLR killers by aggregated IgG was found in our experiments at the end 
of 1 wk in culture. This is consistent with our previously reported observation that the 
removal of Fc gamma-positive cells by adherence  to immune complexes could  not 
deplete AMLR killer activity (17).  In a  few experiments, a slight decrease in AMLR 
killer  activity  was  noted  after  treatment  with  NK-specific  MAb  and  C'  or  with 
aggregated IgG, so a  small part of the killing may be attributable to surviving NK 
cells. This is consistent with the observation that 5-10% of the cells remaining at the 
end of 1 wk in the AMLR and control cultures were OKM1 +, Leu-7  +, and Fc receptor 
positive (Table III). 
The AMLR cytotoxic effector cell appears to be distinct  from the classical CTL 
which  developed  during  allosensitization.  The  latter  are  OKMI-,  OKT3 +,  and 
OKT8  +,  and  displayed  a  cell  surface  activation  antigen  4F2,  but  probably not  Ia 
(51).  ~25%  of the cells  present  after  1 wk in  the AMLR  cultures  stained  with  the 
OKT8  MAb,  but,  surprisingly,  treatment  of the  culture  with  this  reagent  plus  C' 
enhanced  rather  than  ablated  the  cytotoxicity  against  the  K562  target.  Further 
support  for  the  separation  between  CTL  and  AMLR  killer  cells  comes  from  the 
finding that MAb OKT8  + and 9.3, which normally block CTL (in the absence of C') 
(28, 52, 53), had no effect on AMLR killer activity. 
A  source of confusion in  the past stems from the  fact that  at least two cytotoxic 
populations develop during the course of a MLR. The first, the classic CTL, kills the 
allogeneic  target,  whereas  the  other  lyses  a  variety  of cultured  cell  lines  and  is 
independent  of histocompatibility relationships  (16).  The latter appears several days 
earlier in culture and the two can be distinguished by cross cold target inhibition  (54, 
55).  Their coexistence may account  for the discrepant  results obtained using MAb 
and C' to define the phenotype of the responsible cells. In such studies,  diminution 
without  complete elimination  of cytotoxic activity  is  usually  ascribed  to  the  lesser 
sensitivity of this method as compared with cell sorting or the fact that the cells with 
fewer surface antigens escape the C'-mediated effects (28). Alternatively, the observed 
cytotoxicity can be caused by two cell populations with different phenotypes. Such 
mixtures might explain why, for instance, Grimm et al. (56) could not totally eliminate 
CTL activity  produced  in  the  allo-MLR  with  C'-mediated lysis using  OKT3  and 
OKT8 antibodies. 
The cells that the AMLR killers most closely resemble are the nonspecific cytotoxic MAKOTO GOTO AND NATHAN J. ZVAIFLER  1319 
cells variously described as NK-like, anomalous killers, or lymphokine-activated killer 
cells (LAK) (56). Typically, this class of cytotoxic cells is comprised of T  lymphocytes 
that have a broad range of target specificities, lack Fc receptors, and show a limited 
number of characteristic cell surface antigens.  They all  appear to express the 4F2 
phenotype (Table V). 
The  relationship  of the  various  cytotoxic effector cells;  i.e.,  conventional  NK, 
induced NK-like, and allospecific CTL, to one another is unresolved. One suggestion 
is that they represent different stages in the development or maturation of a  single 
lineage.  The  finding  that  the  AMLR  killers  display  activation  antigens,  but  not 
OKT8, could reflect the lack of a  differentiation signal provided by an allospecific 
stimulus.  We  favor an  alternative  view;  namely,  that  the  two  are  distinct  T  cell 
populations. Two lines of evidence can be cited. First, MLC-generated CTL and NK- 
like cells have separate target specificities when analyzed in a single cell binding and 
cytotoxicity assay (54). Second, the subset ofT lymphocytes that respond to autologous 
stimulation is separable from alloreactive T  cells (55, 57). 
According to MacDonald and Lees (58) cytotoxic T  cell activity can be induced in 
the  allogeneic  MLR  independently of DNA  synthesis.  On  the  other  hand,  DNA 
synthesis appears to be required for the generation of AMLR killing, as reported by 
others (16), and in this paper (Table V). The peaks for each response were dissociated, 
and no clear-cut correlation was observed between [aH]thymidine uptake and AMLR 
killer activity. Blast  transformation,  DNA  synthesis,  and  cell proliferation  are  not 
synonymous, however, and instances have been reported where [aH]thymidine incor- 
poration  has  occurred  without  demonstrable  cell  division  (59).  Grimm  (56)  has 
suggested that the LAK system is probably the common pathway that explains most 
of the  nonclassic  cytotoxic  cells.  If  she  is  correct,  and  nonspecific  cytotoxicity, 
anomalous killers, and other unusual forms of killer cells are the result of activation 
of precursor T  lymphocytes by interleukin 2 (IL-2), then proliferation would appear 
to be common to all of them. IL-2 is unquestionably made in the AMLR, and cellular 
proliferation appears to be directly related to its production (9,  11,  12). From studies 
in progress, however, we would question whether IL-2-stimulated proliferation alone 
TABLE  V 
Characteristics of Cells with Cytotoxic Capacity 
Cell surface phenotype 
Cell  pan T  CTL  NK 
type  IgG Fc  (Leu-l,  (OKT8,  Ia (OKI.t)  (OKMI,  Activated 
OKT3,  T  (4F~) 
9.3)  Leu-7) 
Tloh 9.6) 
Sensitivity  Requirement 
Day of  against mi-  ofprolifera- 
peak  togen-stimu-  tion for the 
activity  lated auto-  generation of 
logous  cells  killer cells 
Reference 
NK 
CTL 
LAK 
AMLR 
Killer 
+*  +  --~  --  +  0  --  --  18-20, 28, 41, 
43, 48-50§ 
-  +  +  -[I  -  +  5-7  -  +l[  21-22, 28, 37, 
40, 48, 51 
52, 58, 60 
NR¶  +  +  NR  --  +  5- 7  --  +  56 
--  +  -  --  --  +  7-9  +  +  13, 15-17§ 
* Usually present. 
Usually absent. 
§ Discussed in thispaper. 
II Conflicting data were also reported. 
¶ Not reported. 1320  AUTOLOGOUS MIXED LYMPHOCYTE  REACTION-GENERATED  KILLER CELLS 
is  sufficient  for the  production  of auto-MLR  killers,  since  cells  from patients  with 
certain  diseases  (rheumatoid  arthritis  as an example)  give a  near normal  thymidine 
incorporation but produce very few cytotoxic cells at the end of seven days in culture 
(manuscript  in preparation). 
Summary 
Cytotoxic cells are produced in an autologous mixed leukocyte reaction  (AMLR). 
At 1 wk in culture the AMLR killers are mainly IgG Fc- cells and can kill autologous 
lymphoblastoid  cell  lines  and  Raji  and  Daudi  targets  that  are  usually  resistant  to 
natural  killer  cell  (NK)  lysis.  To  define  the phenotype  of these  cells,  we have used 
complement  (C')-mediated  lysis  with  monoclonal  antibodies  (MAb).  AMLR  killer 
activity  was  virtually  eliminated  by  treatment  with  C'  and  9.6  or  4F2,  but  the 
cytotoxic cells did not express NK-specific antigens, OKM1  and Leu-7, nor cytolytic 
T  lymphocyte-specific antigens,  9.3  and  OKT8.  None  of the  10  MAb  used  could 
significantly  block  cytotoxicity at  the  final  concentration  of 1.5  mcg/ml  which  is 
generally sufficient to inhibit  CTL. The majority of cells at  1 wk in AMLR cultures 
stained  with T  cell activation antigens Ia and 4F2; AMLR  killing was proportional 
to the percentage of 4F2  + cells but unrelated to the expression of Ia antigen. 
The authors wish to thank  Ms.  Leslye  Rucker for her excellent secretarial  assistance,  Doug 
Redelman for useful discussion and review of the manuscript, and Anthony Fauci for generous 
supplies of the 4F2 monoclonal antibody. 
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